ARTICLE | Clinical News
Shigamabs: Phase II/III delayed
March 31, 2008 7:00 AM UTC
Thallion delayed the start of an international Phase II/III trial of Shigamabs by 6 months to 4Q08 in order to conserve capital and extend its other pipeline candidates. The company said one reason fo...